Intangible Assets

Goodwill



(In thousands)	CooperVision			CooperSurgical		Total
Balance as of October 31, 2011	$	1,046,587		$	229,980	$	1,276,567
Net additions during the year ended October 31, 2012	260			95,348		95,608
Translation	(2,793		)	865		(1,928		)
Balance as of October 31, 2012	1,044,054			326,193		1,370,247
Net additions during the nine-month period ended July 31, 2013	2,961			10,992		13,953
Translation	(6,060		)	539		(5,521		)
Balance as of July 31, 2013	$	1,040,955		$	337,724	$	1,378,679

We performed our annual impairment assessment in our fiscal third quarter of 2013, and our analysis indicated that we had no impairment of goodwill. We performed our annual impairment assessment in our fiscal third quarter of 2012, and our analysis indicated that we had no impairment of goodwill. We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. We account for goodwill and evaluate our goodwill balances and test them for impairment in accordance with related accounting standards.

In fiscal 2013 and 2012, we performed a qualitative assessment to test each reporting unit's goodwill for impairment. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the two step impairment test will be performed. Initially, we compare the book value of net assets to the fair value of each reporting unit that has goodwill assigned to it. If the fair value is determined to be less than the book value, a second step is performed to compute the amount of the impairment. A reporting unit is the level of reporting at which goodwill is tested for impairment. Our reporting units are the same as our business segments - CooperVision and CooperSurgical - reflecting the way that we manage our business.

Goodwill impairment analysis and measurement is a process that requires significant judgment. If our common stock price trades below book value per share, there are changes in market conditions or a future downturn in our business, or a future annual goodwill impairment test indicates an impairment of our goodwill, the Company may have to recognize a non-cash impairment of its goodwill that could be material and could adversely affect our results of operations in the period recognized and also adversely affect our total assets, stockholders' equity and financial condition.

Other Intangible Assets



	As of July 31, 2013				As of October 31, 2012
(In thousands)	Gross Carrying Amount		Accumulated Amortization & Translation		Gross Carrying Amount		Accumulated Amortization & Translation
Trademarks	$	12,354	$	2,165	$	11,254	$	1,632
Technology	132,815		81,304		128,398		72,397
Shelf space and market share	198,410		71,546		192,566		59,269
License and distribution rights and other	23,782		8,948		23,782		7,919
	367,361		$	163,963	356,000		$	141,217
Less accumulated amortization and translation	163,963				141,217
Other intangible assets, net	$	203,398			$	214,783

We estimate that amortization expense for our existing other intangible assets, including the intangible assets acquired from Origio, will be $30.2 million in fiscal 2013, $27.9 million in fiscal 2014, $21.5 million in fiscal 2015, $19.8 million in fiscal 2016 and $19.4 million in fiscal 2017.